Modeling Respiratory Syncytial Virus Adult Vaccination in the United States with a Dynamic Transmission Model.
T Van EffelterreNiel HensL J WhiteS GravensteinA R BastianN BuyukkaramikliC-Y ChengJ HartnettG KrishnarajahK WeberL Hernandez PastorPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
The model provides estimated burden of RSV in the US across all age groups, with substantial burden projected specifically in older adults. Vaccination of ≥ 60 years-old population could significantly reduce the burden of disease in this population, with additional indirect effect in the < 60 years-old population due to reduced transmissibility.
Keyphrases